(Q36212901)

12 August 2017

1 reference

title

Follow-up in patients with localised primary cutaneous melanoma (English)

1 reference

12 August 2017

Anne Brecht Francken

1

1 reference

12 August 2017

Esther Bastiaannet

series ordinal

2

1 reference

12 August 2017

Harald J Hoekstra

series ordinal

3

1 reference

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Lancet Oncology Commission

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

8

1 reference

12 August 2017

page(s)

608-621

1 reference

Contemporary surgical treatment of advanced-stage melanoma

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Management of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

The epidemiology of skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

The incidence of malignant melanoma in the United States: issues as we approach the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Melanoma recurrence surveillance. Patient or physician based?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Follow-up in stage I cutaneous malignant melanoma: an audit

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Multiple primary melanomas: implications for screening and follow-up programs for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Management of Melanoma Patients: Benefit of Intense Follow-Up Schedule Is Not Demonstrated

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Recommendations for an Effective Follow-Up Strategy in Melanoma Patients Should Be Tailored to the Investigations Performed During Initial Staging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Follow-up of patients with a thin melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Frequency and duration of patient follow-up after treatment of a primary malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

First recurrence analysis of 840 cutaneous melanomas: a proposal for a follow-up schedule

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Recurrence of thin melanoma: how effective is follow-up?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Data on first recurrence after treatment for malignant melanoma in a large patient population.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Late relapse from cutaneous stage I malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

The incidence of late recurrence (greater than 10 years); an analysis of 536 consecutive cases of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Late recurrence of malignant melanoma. Analysis of 168 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Late recurrence of stage I malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Lack of predictive factors in late recurrence of stage I melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Late (> 10 years) recurrence of melanoma: the Scottish experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Late metastases of cutaneous melanoma: an analysis of 31 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Recurrence potential of thin primary melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Is long-term follow-up justified after excision of a thin melanoma (less than or equal to 1.5 mm)? A retrospective analysis of 206 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Compliance with follow-up and prognosis among patients with thin melanomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Disease progression in patients with thin cutaneous melanomas (tumour thickness <= 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Malignant melanoma, evaluation of clinical follow up by questionnaire survey

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Follow-up requirements for thick cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Multiple primary cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Multiple primary melanomas: data and significance.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Multiple primary melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Multiple primary melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Significant risk of a second melanoma in patients with a history of melanoma but no further predisposing factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Multiple primary melanoma: risk factors and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

The efficacy of laboratory studies in the detection of recurrent melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Geographic and patient variation in receipt of surveillance procedures after local excision of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Malignant melanoma: impact of superficial US on management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage i cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Lymph node sonography versus palpation for detecting recurrent disease in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Routine ultrasonography in melanoma follow-up?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Psychological reactions in patients with malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Six-month follow-up of effects of an information programme for patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Psychological responses of patients receiving a diagnosis of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

U.K. guidelines for the management of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

Routine follow up of breast cancer in primary care: randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970283-7

7 January 2021

10.1016/S1470-2045(05)70283-7

Identifiers

DOI

1 reference

12 August 2017

1 reference